We performed scRNA-seq and flow cytometry analyses of CD45+ cells from YUMM1.7OVA NTT tumours, RTT control (CTRL) tumours, RTTPtgs1/2 KO tumours and RTT IRF3/7 overexpressing tumours 72 h after ACT (Fig. 4a and Extended Data Fig. 6a–e). This evidence concerns the gene IRF3 and neoplasm.